Annual Accounts Payable
$2.25 M
-$1.84 M-45.01%
December 31, 2024
Summary
- As of March 4, 2025, CMPX annual accounts payable is $2.25 million, with the most recent change of -$1.84 million (-45.01%) on December 31, 2024.
- During the last 3 years, CMPX annual accounts payable has risen by +$1.38 million (+159.40%).
- CMPX annual accounts payable is now -45.01% below its all-time high of $4.09 million, reached on December 31, 2023.
Performance
CMPX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.25 M
+$1.29 M+134.27%
December 31, 2024
Summary
- As of March 4, 2025, CMPX quarterly accounts payable is $2.25 million, with the most recent change of +$1.29 million (+134.27%) on December 31, 2024.
- Over the past year, CMPX quarterly accounts payable has increased by +$1.40 million (+163.35%).
- CMPX quarterly accounts payable is now -65.57% below its all-time high of $6.53 million, reached on June 1, 2022.
Performance
CMPX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CMPX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.0% | +163.3% |
| 3 y3 years | +159.4% | +163.3% |
| 5 y5 years | +257.6% | +163.3% |
CMPX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.0% | +159.4% | -65.6% | +775.1% |
| 5 y | 5-year | -45.0% | +257.6% | -65.6% | +775.1% |
| alltime | all time | -45.0% | +257.6% | -65.6% | +775.1% |
Compass Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.25 M(-45.0%) | $2.25 M(+134.3%) |
| Sep 2024 | - | $960.00 K(-19.5%) |
| Jun 2024 | - | $1.19 M(+39.6%) |
| Mar 2024 | - | $854.00 K(-79.1%) |
| Dec 2023 | $4.09 M(+20.9%) | $4.09 M(+77.4%) |
| Sep 2023 | - | $2.31 M(+218.5%) |
| Jun 2023 | - | $724.00 K(-35.6%) |
| Mar 2023 | - | $1.13 M(-66.7%) |
| Dec 2022 | $3.38 M | $3.38 M(+22.5%) |
| Sep 2022 | - | $2.76 M(-57.7%) |
| Jun 2022 | - | $6.53 M(+2441.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $257.00 K(-70.4%) |
| Dec 2021 | $867.00 K(-18.3%) | - |
| Dec 2021 | - | $867.00 K(-0.1%) |
| Sep 2021 | - | $868.00 K(+55.3%) |
| Jun 2021 | - | $559.00 K(-47.3%) |
| Mar 2021 | - | $1.06 M(0.0%) |
| Dec 2020 | $1.06 M(+68.7%) | $1.06 M(+24.2%) |
| Sep 2020 | - | $854.00 K(-46.0%) |
| Jun 2020 | - | $1.58 M(+151.4%) |
| Dec 2019 | $629.00 K(-63.6%) | $629.00 K |
| Dec 2018 | $1.73 M | - |
FAQ
- What is Compass Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Compass Therapeutics?
- What is Compass Therapeutics annual accounts payable year-on-year change?
- What is Compass Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Compass Therapeutics?
- What is Compass Therapeutics quarterly accounts payable year-on-year change?
What is Compass Therapeutics annual accounts payable?
The current annual accounts payable of CMPX is $2.25 M
What is the all time high annual accounts payable for Compass Therapeutics?
Compass Therapeutics all-time high annual accounts payable is $4.09 M
What is Compass Therapeutics annual accounts payable year-on-year change?
Over the past year, CMPX annual accounts payable has changed by -$1.84 M (-45.01%)
What is Compass Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CMPX is $2.25 M
What is the all time high quarterly accounts payable for Compass Therapeutics?
Compass Therapeutics all-time high quarterly accounts payable is $6.53 M
What is Compass Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CMPX quarterly accounts payable has changed by +$1.40 M (+163.35%)